LNTH Lantheus
- 76.020
- +0.120+0.16%
- 75.500
- -0.520-0.68%
Lantheus News
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q1 2024 Earnings Call Transcript
Lantheus (LNTH) Q1 Earnings Surpass Estimates, Gross Margin Up
Lantheus Holdings Price Target Raised to $96.00/Share From $82.00 by Truist Securities
Lantheus Holdings Price Target Raised to $96.00/Share From $82.00 by Truist Securities
Evaluating Lantheus Holdings: Insights From 5 Financial Analysts
Lantheus Holdings (NASDAQ:LNTH) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.The following table encapsulates their recent ratings,
Truist Raises Lantheus Holdings' PT to $94 From $82 After 'Solid' Q1 Beat, Keeps Buy Rating
Lantheus Holdings (LNTH) has an average rating of buy and price targets ranging from $83 to $128, according to analysts polled by Capital IQ. Price: 78.18, Change: +10.79, Percent Change: +16.01
Strong Buy Rating for Lantheus Holdings Amidst Robust Financials and Growth Prospects
Lantheus Holdings Is Maintained at Buy by Mizuho
Lantheus Holdings Is Maintained at Buy by Mizuho
Mizuho Bank: Maintaining the Lantheus Holdings (LNTH.US) rating, adjusted from buy to buy rating, and adjusted the target price from $90.00 to $100.00.
Mizuho Bank: Maintaining the Lantheus Holdings (LNTH.US) rating, adjusted from buy to buy rating, and adjusted the target price from $90.00 to $100.00.
Mizuho Maintains Buy on Lantheus Holdings, Raises Price Target to $100
Mizuho analyst Anthony Petrone maintains Lantheus Holdings with a Buy and raises the price target from $90 to $100.
Lantheus Holdings Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/03/2024 27.73% Mizuho $90 → $100 Maintains Buy 04/18/2024 26.45% B. Riley Securities $95 → $99 Maintain
Analysts' Top Healthcare Picks: Lantheus (LNTH), Bicycle Therapeutics (BCYC)
Earnings Call Summary | Lantheus(LNTH.US) Q1 2024 Earnings Conference
The following is a summary of the Lantheus Holdings, Inc. (LNTH) Q1 2024 Earnings Call Transcript:Financial Performance:Lantheus reported consolidated Q1 2024 net revenue of $370 million, a 23% increa
Radiopharma Stocks Higher as Sector Welcomes the Latest M&A Deal
Lantheus Holdings Shares Climb on Strong 1Q, FY Outlook Raise
By Dean Seal Shares of Lantheus Holdings climbed after the company raised its annual guidance and posted stronger profit and revenue growth for the first quarter than analysts had been expecting. Th
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining over 50 points on Thursday.Shares of C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) rose sharply during Thursday's session after the company repo
SonoVascular Enters Into Strategic Collaboration With Lantheus Holdings, Inc. for Use of Microbubbles in Combination With SonoThrombectomyTM System for Treatment of Venous Thromboembolism
SonoVascular, Inc., a private medical device company focused on the development of its SonoThrombectomy System, a novel pharmaco-mechanical...
Lantheus Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Results and Raised Its FY24 Adjusted EPS Outlook.
Lantheus Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Results and Raised Its FY24 Adjusted EPS Outlook.
Lantheus Holdings Inc (LNTH) Surpasses Q1 2024 Revenue and Earnings Estimates
Lantheus Holdings (LNTH.US): The 2024 Q1 financial report achieved revenue of US$370 million, with a previous value of US$300.8 million and an expected value of US$348.5 million; earnings per share were US$1.69, previous value was US$1.47, and expected va
Lantheus Holdings (LNTH.US): The 2024 Q1 financial report achieved revenue of US$370 million, with a previous value of US$300.8 million and an expected value of US$348.5 million; earnings per share were US$1.69, previous value was US$1.47, and expected value was US$1.54.
GUIDANCE: (LNTH) LANTHEUS HOLDINGS Sees Q2 EPS Range $1.81 - $1.86
07:12 AM EDT, 05/02/2024 (MT Newswires) -- GUIDANCE: (LNTH) LANTHEUS HOLDINGS Sees Q2 EPS Range $1.81 - $1.86
Analysis
Price Target
No Data
